ABSTRACT The major apoprotein of high density lipoprotein is apolipoprotein A-I (ApoA-I). In addition to being a structural component of this class of lipoproteins, ApoA-I also has a physiologic role as an activator of lecithin-cholesterol acyl transferase, an enzyme important in the metabolism of all lipoproteins.
INTRODUCTION
Much has been learned recently about the structure and metabolism of the high density lipoproteins (HDL) ' of plasma-the density class which carries most of the plasma phospholipids and a large portion of the cholesterols (1, 2) . About 50% of HDL by weight is composed of several apoproteins (ApoHDL), the major class of which is apolipoprotein A (ApoA)
The apolipoproteins appear to have important structural and physiologic functions. For example, ApoC-II is an activator of lipoprotein lipase (7, 8) and ApoC-III is an inhibitor (9) . ApoA-I is important in the structural integrity of HDL (5) as well as in the activation of lecithin-cholesterol acyl transferase (LCAT) (10) an enzyme of great importance in lipoprotein metabolism (11, 12) . The consequences of ApoA-I deficiency are well exemplified in Tangier disease where both HDL structure and VLDL metabolism appear to be abnormal (6) . It is possible that subtle qualitative or quantitative abnormalities of ApoA-I may play a role in the pathogenesis of some of the familial hyperlipoproteinemias as classified by Fredrickson, Levy, and Lees (13) or in some of the lipoprotein disorders secondary to other diseases. However, studies of ApoHDL in disease states and studies of the normal structure and metabolism of HDL have been hampered by the absence of suitable assays. We report, herein, the development of a radioimmunoassay (RIA) for the ApoA-I component of ApoHDL and the results obtained with it in some metabolic and structural studies. Some of these results have been reported previously in abstract form (14, 15) . Recently, another assay for ApoA-I has been reported in abstract form (16) .
METHODS
Isolation of HDL. HDL was isolated from the plasma of a 47-yr-old normal male donor, who was eating an ad lib diet, as follows: after a 16-h fast the patient donated 2 U of blood, which were collected in acid citrate dextrose solution. After separation, the red cells were reinfused, and the plasma was dialyzed against 0.16 M NaCl, 1 mM in disodium EDTA, pH 8.6 (EDTA-saline).
After dialysis, the background density of the plasma was raised with solid KBr to a calculated density of 1.18 (2) . (Densities of salt solutions prepared in parallel were checked by pyknometry.) The first ultracentrifugation was carried out in a 60 Ti rotor in a Beckman L265B instrument (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) at 50,000 rpm, at 10'C for 20 h. The resulting supernate, containing nearly all of the lipoproteins (d < 1.18) , was removed with a Pasteur pipette and transferred to new tubes. A solution of KBr (d 1.18, pH 8.6) was layered over the lipoproteins and they were recentrifuged as above. The resulting supernate, containing "washed" lipoproteins, was diluted with EDTA-saline to a calculated density of 1.090 and centrifuged under the same conditions described above. The infranate, which consisted of material of d 1.090-1.18, was dialyzed against EDTA-saline and analyzed immunologically. It contained only ApoA and ApoC by immunodiffusion against the appropriate antisera. No ApoB, albumin, or other serum proteins were detectable. The 1.090-1.18 density range was used only as the starting material for the preparation of ApoA-I, in order to avoid possible contamination by Lp(a) (17) and by nonlipoprotein proteins. For routine applications HDL was isolated between the densities 1.063 and 1. 21 .
Isolation of ApoA-I. HDL was dialyzed against 0.1 M Tris-HCl, pH 8.6, 1 mM in disodium EDTA (Tris-EDTA) (18, 19) . Peaks were pooled and subjected to disk electrophoresis in 9%o polyacrylamide, pH 8.9, 6 M urea and stained with Coomasie Blue. Peak II represents ApoA-I, peak III is ApoA-II, peak IV is ApoC. Peak I contains several slowly migrating proteins.
and delipidated with ether-ethanol solutions according to Scanu and Edelstein (18) . 85-95% of the protein was recovered from this step. The resulting ApoHDL was solubilized in Tris-EDTA buffer and separated by gel chromatography on a 2.5 X 90-cm column containing Sephadex G-200 equilibrated with Tris-EDTA, 8 M in urea, as described by Scanu, Toth, Edelstein, Koga, and Stiller (19) (Fig. 1) . 10-15 mg of protein were applied and recovery of protein averaged 95%. The ascending portion and the "top" of the peak corresponding to ApoA-I was dialyzed against 1 mM EDTA, pH 8.6, and lyophilized. To reduce the possibility of contamination by ApoA-II, the descending portion of the peak was not utilized.
ApoA-I prepared in this way migrated as a single band ( Fig. 1 ) in the appropriate positions on disk electrophoresis (9% polyacrylamide, 6 M urea, pH 8.9) and yielded a single immunoprecipitin band on immunodiffusion and immunoelectrophoresis against anti-HDL antisera (20) (see also Fig. 7 ). It did not react with antisera raised against ApoA-II, ApoB, ApoC, or other serum proteins. When there were questions as to the purity of a given ApoA-I preparation, it was rechromatographed on Sephadex G-200 as above. Upon injection of ApoA-I into rabbits (see below) antisera were produced which did not react against ApoA-II or ApoC.
Some workers have found that Apo-I migrates as several bands on disk electrophoresis and elutes in at least three separate peaks on DEAE-cellulose chromatography (21) . This microheterogeneity may be due to small differences in total amino acid composition. Others have not found a similar degree of heterogeneity (22) . Our ApoA-I preparations were not chromatographed on DEAE-cellulose, thus some microheterogeneity may have been present in these preparations. However, there were no proteins other than ApoA-I present by the criteria outlined above.
Radioimmunoassay for Human High Density Apolipoprotein
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No 0 To quantify the various proteins of ApoHDL, the areas under the peaks of the elution profiles were measured by planimetry (Fig. 1) . ApoA-I content, expressed as percent of total area under the curve, was 66±4% in six HDL preparations (mean-1 SD). In two ApoHDL preparations, the protein content of each of the elution peaks was also determined by the Lowry procedure (23). ApoA-I represented 57 and 65% of the protein of HDL by planimetry, and 53 and 59% by Lowry, respectively.
Preparation of antisera. 0.5-1.0 mg amounts of ApoA-I were dissolved in 0.5 ml H20 and emulsified in an equal amount of complete Freund's adj uvant (Difco Laboratories, Detroit, Mich.). Three rabbits were injected subcutaneously on three occasions 2 wk apart and bled 8-9 days after the last injection. Two of the rabbits were given "booster" injections and rebled. Sodium azide 0.01% was added to the antisera which were stored frozen at -20'C.
The five different antisera were tested against a number of plasma fractions and apoproteins by immunodiffusion and immunoelectrophoresis (20) (Table I) ; they appeared to be monospecific. Anti-rabbit IgG antisera were produced in goats.
Iodination of ApoA-I. 1 and subjected to electrophoresis on paper in a Beckman Durrum Cell using 0.05 M barbital buffer, pH 8.6, for 16 h. At the end of electrophoresis the paper was dried in an oven, cut into 4-mm strips, and counted on a Packard gamma spectrometer. The strips were then stained with bromophenol blue. ApoA-I migrated to the alphai globulin area. The FIGURE 3 Electrophoretic mobility of ['I] ApoA-I. '5I-labeled ApoA-I was mixed with NIRS, "cold" ApoA-I, or anti-ApoA-I antiserum and subjected to electrophoresis on 1% agarose. Electropherograms were cut into strips, radioactivity was determined in a gamma counter, location of proteins was ascertained with Amido Schwartz.
radioactivity due to ['I]ApoA-I coincided with the stained band produced by ApoA-I. A similar experiment was carried out using 1% agarose as the electrophoretic medium (Fig. 3) .
['I]ApoA-I was added to each one of the following and the resulting mixtures were subjected to electrophoresis: "cold" ApoA-I, NIRS, and rabbit antiApoA-I antiserum. 90% of ['I]ApoA-I migrated with ApoA-I to the alpha globulin area. Migration was almost completely blocked by anti-ApoA-I antiserum but not by NIRS.
(b) ['I]ApoA-I was added to ApoA-I and chromatographed on a 0.9 X 30-cm column containing Sephadex G-75 equilibrated with barbital buffer. The radioactive counts (95% of which were recovered) eluted in a single symmetrical peak which coincided with the protein (read at 280 nm) (Fig. 2) . (c) 80-90% of ['I]ApoA-I was precipitated in the RIA in the presence of excess antibody. A similar percentage was precipitated by 10% TCA.
The assay curve. In the absence of "cold" ApoA-I, 80-90% of ['I]ApoA-I counts were precipitated by each of five different anti-ApoA-I antisera. For routine use, antisera were diluted (1: 500 to 1: 1,500) to give precipitabilities of 70-75% in the absence of unlabeled ApoA-I (Bo/T). With these dilutions, as increasing amounts of "cold" ApoA-I were added (1-50 ng), a typical RIA curve was obtained (Fig. 4) Each of the five anti-ApoA-I antisera and the two anti-HDL antisera which were produced yielded acceptable standard curves.
ApoA-I in HDL. HDL isolated from four normal, three type IV, and two type III subjects produced standard curves which paralleled those produced by ApoA-I. However, 20-90 times more ApoHDL than ApoA-I were needed to produce equal amounts of displacement (n = 22). The reactivity of HDL preparations diminished with storage at 40C (preparations up to 8 wk old were tested), accounting for the variability of HDL preparations. Nevertheless even the "freshest" HDL had only about 1/20th the reactivity of ApoA-I. Assays utilizing another anti-ApoA-I antiserum (no. 1) yielded similar results.
The possible explanations for the relatively poor reactivity of HDL were: (a) that ApoA-I represented only a small fraction of ApoHDL, (b) that the rates of equilibration of ApoA-I and HDL with the rest of the RIA system differed because of differences in the sizes of ApoA-I and HDL, and (c) that the structure of HDL is such as to make most of its ApoA-I complement unreactive in this system. Since ApoA-I comprised about 66% of ApoHDL by column chromatography (see Methods, Fig. 1 , and Refs. 19, 21, 30) the first possibility was ruled out. To study the second question, i.e., the possible effects of differential reaction kinetics on the activities of HDL and ApoA-I relative to each other, five pairs of standard curves were set up, each pair consisting of an ApoA-I and an HDL curve. Each ApoA-I curve contained identical components with every other ApoA-I curve and each HDL curve was identical with every other HDL curve, but the time at which ["I]ApoA-I was added relative to the rest of the reactants was varied for each of the pairs. Thus, at 0 time ["I]ApoA-I was added to each member of the pair at the same time with the rest of the reactants; at 6 h label was added 6 h after the other reactants, etc. This experimental design allowed for increasing periods of preincubation of unlabeled ApoA-I or HDL with anti-ApoA-I antibody before the addition of [PI]4ApoA-I, giving the unlabeled moieties a "competitive advantage" vis-A-vis the label. This would result in apparent increases in the reactivity of both ApoA-I and HDL (31) . It was expected, that if the relative lack of reactivity of HDL was due to kinetic considerations, the increases in the reactivities of HDL and ApoA-I would not be parallel in time-course or magnitude.
It is evident (Fig. 5 ) that preincubation did produce the expected rises in the activities of both the standards. (Table II) . These findings suggest that differences in kinetics of reaction accounted for only a small fraction of the greater reactivity of ApoA-I compared with HDL.
To expose more of the ApoA-I in HDL, "intact" HDL was subjected to a variety of disruptive treatments, including repeated freezing and thawing, disaggregation with 8 M urea or 6 M guanidine hydrochloride, or delipidation with ether or ether-ethanol solutions followed by exposure to urea (see Methods).
HDL subjected to such treatments continued to displace counts in parallel with ApoA-I (Fig. 6 ). Freezing and thawing doubled the reactivity of HDL; urea and guanidine HCL each increased it fivefold. 12-20-fold rises in reactivity were obtained by ether and etherethanol extraction and treatment with 8 M urea (Fig.  6) . Thus, disruption of HDL structure resulted in increased reactivity. It is worth noting that the agerelated variability of "intact" HDL noted above disappeared after solvent extraction, i.e., fresh and aged HDL preparations displaced counts to the same extent after extraction.
A number of workers have shown that disruptive manipulations of HDL yield protein-containing "fragments" of variable sizes and densities (32) (33) (34) (35) .
Fresh plasma yielded three protein peaks on column chromatography (OD at 280 nm): the first peak contained ApoB, asM, and IgM, the second, IgG, and the third, albumin. ApoA-I was eluted in three broad peaks corresponding to approximate mol wts of 320,000, 155,-000, and 50,000. The third peak was rechromatographed on Sephadex G-75; ApoA-I activity, together with albumin, eluted in a single peak near the void volume, ApoA-I activity was not detected in any smaller mol wt fractions. When d> 1.21 fractions of plasma were chromatographed on Sephadex G-200, three protein peaks were again obtained, but ApoA-I was detectable only in the 50,000 mol wt peak.
Each of the Sephadex G-200 peaks was pooled, extracted with ether, and assayed for ApoA-I by RIA. Peaks 1, 2, and 3 contained 42, 45, and 13% of the total ApoA-I, respectively. 87% of applied ApoA-I was recovered from the column (sum of pools X 100/whole plasma).
The three pooled peaks were also assayed before extraction to ascertain the increases in reactivity produced by the extraction procedure. The increases for peaks 1, 2, and 3 were 17-, 14-, and 2-fold, respectively. Thus, fractionation of plasma by ultracentrifugal and column chromatographic procedures both yielded Patients were referred to the Washington University Lipid Research Center with known or suspected hyperlipoproteinemia or premature atherosclerosis. Normals included laboratory personnel, students, and patients found to be normolipemic. Pregnant women were in their second and third trimesters. Normal subjects had total TG and LDL-Chol levels of <200 mg/dl. Type II had LDL-Chol >200 mg/dl and total TG <200 mg/dl. Type IV had total TG >200 and LDL-Chol <200 mg/dl.
large mol wt fractions, the reactivity of which was greatly increased by extraction, and a 50,000 mol wt fraction which sedimented at d = 1.21. This fraction contained about 10% of the ApoA-I in normolipemic plasma and was much less affected by extraction. ApoA-I levels in plasma. Plasmas drawn from one type I, five type II, two type III, six type IV, and one type V patients displayed parallelism with ApoA-I (Fig. 8) . The apparent ApoA-I concentrations of untreated plasmas ranged from 4.8-14.4 mg/dl in assays using ApoA-I standards. These results were considerably lower than expected (36) . Therefore, plasmas were extracted with ether-ethanol and treated with urea as described above for HDL. -Parallelism with ApoA-I was retained (Fig. 6 ) and the reactivity of the plasmas was increased 10.5±2.1-fold (n= 30).
To check further on the ability of the assay to detect all of the ApoA-I present in plasma, ApoA-I or HDL were added to plasma, and the mixtures were extracted and processed as above. Recovery of added ApoA-I was 95±10% (n = 12). An ApoA-I-plasma mixture was also assayed without extraction; 99±3% (n = 3) of added ApoA-I was recovered. Finally, five extracted plasmas were assayed with five different anti-ApoA-I antisera (Table III) . Four of the five antisera yielded comparable results. Assays using one antiserum (no. 3) consistently gave lower results. (Antiserum no. 5 was used routinely.)
The mean ApoA-I contents of normal whole plasmas, measured after extraction, were about 100 mg/dl. Major departures from normal were found in pregnant women (twice normal) but not in familial types II and IV hyperlipoproteinemia (Table IV) . We also measured the plasma ApoA-I contents of a 47-yr-old white man in whom hyperlipemia was found on a routine medical examination. Medical (Table IV) , whereas correlations between total Chol and ApoA-II were not significant (not shown). DISCUSSION The assay. The HDL transport most of the phospholipids of plasma; thus they provide most of the lecithin-substrate for the LCAT reaction (11) . The ApoA component, ApoA-I is an activator of LCAT (10), while ApoC contains proteins which both activate (ApoC-Il) and inhibit (ApoC-III) lipoprotein lipase (7) (8) (9) . Gross distortions of lipoprotein structure and metabolism follow deficiencies of either LCAT (12) or of ApoHDL (6) . Thus both the lipid and protein components of HDL are important physiologically and structurally. In spite of this, it has not been possible to quantify ApoHDL in plasma except by very laborious procedures involving isolation of the lipoproteins from plasma, followed by extraction and isolation of the individual apoproteins by column chromatography (19, 21, 30) . Therefore, the development of a reliable assay for ApoA-I, the major protein of ApoHDL, was thought to be a useful addition to the available methodology for studying lipoprotein metabolism.
Any assay must meet criteria of specificity, precision, accuracy, and sensitivity before it can be deemed useful (37) . In RIA, specificity is determined by the purity of the tracer (31) . Our ApoA-I preparations met several of the commonly accepted criteria of purity, including the most stringent-the ability to stimulate the production of monospecific antisera. The precision of the assay compares favorably with the RIA for ApoB (35) , and with other RIAs (38 ApoA-I represented 51% of ApoHDL by RIA compared to 66% by chromatography. This discrepancy may reflect an underestimate of the ApoA-I content of HDL by RIA, which could occur if the extraction and urea treatments do not expose all of the ApoA-I to antibody. (It is unlikely that ApoA-I determinants are destroyed since the ApoA-I standard is isolated in the same way.) On the other hand, physical methods may overestimate ApoA-I contents, if disproportionate losses of protein are sustained during the complicated processes of purification. Thus it is difficult to decide which results are the more valid. However, reasonable agreement exists between the immunologic and physical methods. In addition, the ApoA-I levels obtained here are not too different from those obtained by direct analysis of isolated HDL fractions (36) and by another RIA recently reported in abstract form (16) . The assay, therefore, represents a distinct improvement over available methods.
ApoA-I in HDL. HDL was much less reactive in the assay than was expected from its ApoA-I content by column chromatography. This could have been due to causes related (a) to the technique of the assay, (b) to the characteristics of the immunologic reactions, or (c) to the structure of HDL itself.
The kinetic experiment showed that while there were some slight differences in the kinetic behavior of ApoA-I and HDL in the RIA, these were probably not of sufficient magnitude to account for the large discrepancies in activities of ApoA-I and HDL. Thus, while the assay as-Toutinely performed may have overestimated the differences between ApoA-I and HDL 2-3-fold, > 40-fold differences still remained even after 42 h of preincubation in this particular experiment.
It is also possible that the immunologic technique affected these results. HDL by virtue of its greater size could have altered the sizes of the immune complexes formed by HDL and anti-ApoA-I so as to effect their precipitability by the anti-rabbit IgG antibody. This possibility is unlikely. Chylomicrons and VLDL are much larger than HDL (1) (2) (3) (4) 40% of it should be exposed and reactive in our system. Since only 5% or less is reactive, it may be that ApoA-I is preferentially arranged on the "interior" surface of each subunit with perhaps the greatest amount of ApoA-I being on the central subunit.
In the spherical model, protein subunits are disposed on the surface of the HDL spheres (4, 41, 42 ). Yet in spite of their surface location only 5% or less of ApoA-I is accessible to antibody. This is in contrast to ApoB all of which appears to be detectable in VLDL and chylomicrons by a similar double antibody RIA system (35) . The unavailability of ApoA-I suggests that most of it is complexed with lipid or other Apo-HDL so as to make it unavailable to antibody in spite of its location on the surface of the spheres. ( The accessability of amino acid side chains to much smaller chemicals (4) does not alter the validity of this argument.)
In normal plasma about 90% of ApoA-I is associated with d < 1.21 and about 10% is in the d > 1.21 fractions. (Trace amounts are also found in the d < 1.063 fractions.) In the d > 1.21 fractions, ApoA-I seems to be part of a molecule with mol wt of 50,000. VHDL and d 1.21 and the smaller mol wt fractions exhibited parallelism with ApoA-I but were activated to a much lesser extent by extraction than was HDL. This implies a simpler structure for these lipoproteins.
Intact HDL isolated from normal and hyperlipoproteinemic subjects displaced ['mI]ApoA-I in parallel with lipid-free ApoA-I standard with each other. One can conclude, that the same antigenic determinants were being detected in intact HDL and in purified ApoA-I, and that the HDL of normals and those with hyperlipoproteinemia are immunologically indistinguishable. Furthermore, extracted plasmas and HDL from normal and patients with hyperlipoproteinemia displaced counts in parallel with each other. This suggests that the ApoA-I of normal and hyperlipoproteinemic subjects is also immunologically identical. (The above conclusions are of course subject to the qualification that rabbit antisera may not detect subtle differences between human proteins. Such relative insensitivity of heterologous antisera has been observed with LDL allotypes (43, 44) .) Total plasma ApoA-I levels were similar in normal and type II and type IV hyperlipoproteinemic subjects.
However, more population studies need to be done to define the distribution of ApoA-I levels in normal subjects and in the various dyslipoproteinemias. The high levels of ApoA-I in pregnancy indicate that metabolic and/or hormonal factors play important roles in altering ApoA-I concentrations. This model based on results obtained by means of nuclear magnetic resonance and circular dichroism predicts that most of ApoA-I in intact HDL would not be available to react in the RIA.
